A Phase 1 Clinical Trial to Evaluate the Safety and Pharmacokinetic Drug-drug Interaction of DHP2302R1 and DHP2302R2 in Healthy Adult Volunteers
Latest Information Update: 29 Jul 2024
At a glance
- Drugs DHP 2302R1 (Primary)
- Indications Unspecified
- Focus Pharmacokinetics
- Sponsors Daehwa Pharmaceutical
Most Recent Events
- 25 Jul 2024 Status changed from active, no longer recruiting to completed.
- 27 Mar 2024 New trial record